Hepatitis C: all 2,356 studies
Page 16 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected PatientsStatus unknownNCT02057003
- Can Vitamin D Supplementation Improve Hepatitis C Cure RatesCompletedNCT02053519Phase 3
- Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy SubjectsCompletedNCT02045966Phase 1
- Drug Interaction & Methadone & BuprenorphineCompletedNCT02045693Phase 1
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- Vertical Transmission of Hepatitis C VirusStatus unknownNCT02044042
- Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT02038387Not applicable
- Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCVCompletedNCT02027493Not applicable
- Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C InfectionCompletedNCT02027116Phase 1
- TD-6450 SAD and MAD in Healthy SubjectsCompletedNCT02022306Phase 1
- Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.CompletedNCT02014571Phase 1
- Prospective Observational Study of Disease Progression in Chronic Hepatitis CActive, not recruitingNCT02011932
- Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV PatientsStatus unknownNCT02008214Phase 4
- Patient Self-management and Gene Guided Therapy for Chronic Hepatitis CCompletedNCT02006823
- Register of Telaprevir and Boceprevir in Routine Clinical PracticeCompletedNCT02004379
- Australian Trial in Acute Hepatitis C Recall StudyCompletedNCT02000063
- Long Term Vitamin D Therapy in HCV Treated PatientsTerminatedNCT01997203Phase 3
- Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesCompletedNCT01988753
- Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis CCompletedNCT01980290
- UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic SubjectsCompletedNCT01979939Phase 3
- UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated CirrhosisCompletedNCT01973049Phase 3
- Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve PatientsCompletedNCT01970904Not applicable
- An Observational Study of Hepatitis C Virus in PregnancyCompletedNCT01959321
- Therapeutic Option for Hepatitis B and C: a French CohortStatus unknownNCT01953458
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisTerminatedNCT01951209Not applicable
- A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCVStatus unknownNCT01949168Phase 2
- Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.WithdrawnNCT01949077
- Observational Study in HCV Chronic InfectionCompletedNCT01945008
- Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)CompletedNCT01937728Phase 4
- A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C PatientsCompletedNCT01928147Phase 1
- The Pathogenesis of Hepatitis C Virus Vertical TransmissionCompletedNCT01921400
- Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)CompletedNCT01919125Phase 1
- Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver TransplantationCompletedNCT01909401Early Phase 1
- Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life ConditionsCompletedNCT01908660
- A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis CCompletedNCT01908335Phase 2
- Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)CompletedNCT01907724Phase 1
- A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis CCompletedNCT01903954Phase 2
- Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis CCompletedNCT01903278Phase 3
- Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis CStatus unknownNCT01900886
- Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis CCompletedNCT01899092Phase 1/2
- Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian PopulationStatus unknownNCT01896609Phase 4
- A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy VolunteersCompletedNCT01891851Phase 1
- Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1WithdrawnNCT01890772Phase 2/3
- The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)WithdrawnNCT01890200Phase 3
- A Health Intervention to Prevent Depression Hepatitis C PatientsTerminatedNCT01890083Phase 2/3
- Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy VolunteersCompletedNCT01889849Phase 1
- An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis CCompletedNCT01889433Phase 3
- Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney DiseaseCompletedNCT01886599Phase 1
- Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4CompletedNCT01884402
- A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy SubjectsCompletedNCT01879462Phase 1
- Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus InfectionStatus unknownNCT01872936Phase 2
- Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis CWithdrawnNCT01871662Phase 2/3
- Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis CCompletedNCT01859962Phase 2
- Open Label Trial to Compare BI 207127 to Telaprevir in HCV PatientsWithdrawnNCT01858961Phase 3
- Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C SubjectsCompletedNCT01856426Phase 1
- Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)CompletedNCT01852604Phase 2
- A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionCompletedNCT01846832Phase 3
- UCLA-Amity Parolee Health Promotion StudyCompletedNCT01844414Not applicable
- A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis CCompletedNCT01842451Phase 2
- Interferon α 2b Pharmacovigilance StudyCompletedNCT01841775Phase 4
- Interaction Between Paroxetine and TelaprevirTerminatedNCT01841502Phase 2
- HCV Treatment in HIV Co-Infected Patients in AsiaCompletedNCT01838772Phase 4
- Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver TransplantationStatus unknownNCT01836718
- Clinical Investigation of Erlotinib as an HCV Entry InhibitorStatus unknownNCT01835938Phase 1/2
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control SubjectsCompletedNCT01827657Phase 1
- Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected PatientsCompletedNCT01825980Phase 1/2
- Pharmacokinetic Interactions Between Telaprevir and Un-boosted AtazanavirCompletedNCT01818856Phase 1
- A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic ImpairmentCompletedNCT01817985Phase 1
- THISTLE - The HIV-HCV Silibinin TrialCompletedNCT01816490Phase 2
- To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)CompletedNCT01813552Phase 1
- Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)CompletedNCT01813513Phase 1
- Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk FactorsWithdrawnNCT01813266
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.CompletedNCT01804829Phase 3
- A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C InfectionCompletedNCT01803308Phase 1
- An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment FailureTerminatedNCT01798576
- Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve PatientsWithdrawnNCT01797848Phase 3
- Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinCompletedNCT01795911Phase 2
- A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01790100Phase 2
- Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CApproved for marketingNCT01779518
- Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in IndiaCompletedNCT01772121
- Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C InfectionCompletedNCT01771653
- A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)WithdrawnNCT01770223Phase 4
- Clinical Pharmacology Study of MP-424CompletedNCT01766167Phase 1
- Hepatitis C Virus Post-Exposure Prophylaxis for Health Care WorkersWithdrawnNCT01766115Phase 4
- Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)Status unknownNCT01760148
- Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian PatientsStatus unknownNCT01758939
- Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis CCompletedNCT01754974Phase 3
- Effects of Vitamin D on Inflammation in Liver DiseaseStatus unknownNCT01754961Phase 2
- Acupuncture as an Adjunctive Treatment for Hepatitis C PatientsStatus unknownNCT01750515Not applicable
- An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT01750216
- A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without CirrhosisCompletedNCT01749150Phase 2
- A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)CompletedNCT01732848
- A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)Status unknownNCT01731301Phase 4
- Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.Status unknownNCT01729221
- Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CStatus unknownNCT01727934Phase 2
- A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01726946Phase 2
- In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced AnaemiaCompletedNCT01726400
- A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C VirusCompletedNCT01724086Phase 2
- 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting AntiviralsTerminatedNCT01721265